Search
for
Sort by
Research 151–180 of 217
- Prophylaxis and Management of Skin Toxicities
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- Management of Dermatologic Toxicities
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- A 32‐year‐old woman with arthralgias and severe hypotension
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia
- Knowledge Mapping of Drug Repositioning’s Theme and Development
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel
- Cancer-Related Alopecia: From Etiologies to Global Management
- Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
- Wound healing protects against chemotherapy-induced alopecia in young rats via up-regulating interleukin-1β-mediated signaling
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Drug-induced scarring and permanent alopecia
- Plumbagin, a Natural Compound with Several Biological Effects and Anti-Inflammatory Properties